NASDAQ:ALVR
AlloVir, Inc. Stock News
$0.760
-0.0300 (-3.80%)
At Close: Jun 13, 2024
U.S. IPO Week Ahead: Software Provider Jamf Takes The Spotlight In A Diverse 4-IPO Week
09:13am, Saturday, 18'th Jul 2020
Four IPOs and one SPAC plan to raise $663 million in the week ahead, led by Jamf Holding. The IPO market is on a hot streak, and the IPO pipeline is filling up as filing activity remains high.
AlloVir Seeks IPO For Anti-Viral Pipeline Development
03:38pm, Thursday, 16'th Jul 2020
AlloVir has filed to raise $100 million in an IPO. The firm is advancing a pipeline of treatments and preventions for various viral diseases, including Covid19.
U.S. IPO Weekly Recap: Preclinical Biotech Nkarta Pops 166% In A 5 IPO Week
08:22am, Sunday, 12'th Jul 2020
Three biotechs, two Chinese issuers, and one SPAC went public this past week. Preclinical oncology biotech Nkarta popped 166% in the best first-day return for a $10+ million IPO since 2015.
